Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Selecting appropriate first-line antiarrhythmic agents: comparative pharmacological profiles.

L A Siddoway1

  • 1Georgetown University School of Medicine, Washington, DC.

Pacing and Clinical Electrophysiology : PACE
|November 1, 1990
PubMed
Summary

Understanding pharmacological issues helps physicians safely treat cardiac arrhythmias by managing symptoms and reducing sudden death risk. This knowledge guides appropriate drug selection and dosing adjustments for better patient outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Immediate- versus controlled-release disopyramide: importance of saturable binding.

Clinical pharmacology and therapeutics·1993
Same author

Pharmacokinetics of recombinant human superoxide dismutase.

Journal of cardiovascular pharmacology·1990
Same author

Suppression of ventricular arrhythmias in man by d-propranolol independent of beta-adrenergic receptor blockade.

The Journal of clinical investigation·1990
Same author

Clinical pharmacokinetics of moricizine.

The American journal of cardiology·1990
Same author

Mexiletine and tocainide: a comparison of antiarrhythmic efficacy, adverse effects, and predictive value of lidocaine testing.

Clinical pharmacology and therapeutics·1989
Same author

Alternating sequence of retrograde atrial activation in patients with dual AV nodal physiology.

Pacing and clinical electrophysiology : PACE·1989

Area of Science:

  • Pharmacology
  • Cardiology
  • Clinical Therapeutics

Background:

  • Cardiac arrhythmias pose significant risks, including sudden death and debilitating symptoms.
  • Effective management requires a deep understanding of antiarrhythmic drug pharmacology.
  • Current treatment strategies aim to balance efficacy with minimizing adverse effects.

Purpose of the Study:

  • To elucidate key pharmacological considerations for treating cardiac arrhythmias.
  • To provide physicians with qualitative insights for optimizing antiarrhythmic therapy.
  • To enhance the safe and effective management of patients with arrhythmias.

Main Methods:

  • Qualitative analysis of pharmacological principles relevant to antiarrhythmic drugs.
  • Review of factors influencing drug selection and dosing in arrhythmia management.

Related Experiment Videos

  • Focus on understanding expected drug behavior rather than memorizing exact quantitative data.

    • Main Results:

    • Physicians can improve arrhythmia treatment by understanding qualitative pharmacological profiles.
    • Knowledge of drug actions and interactions aids in adjusting therapy.
    • Qualitative insights facilitate safer and more appropriate therapeutic decisions.

    Conclusions:

    • A qualitative understanding of pharmacology is crucial for effective arrhythmia management.
    • This approach empowers physicians to tailor treatments for symptom relief and risk reduction.
    • Optimizing antiarrhythmic drug therapy leads to improved patient safety and outcomes.